European Business Summits
info@ebsummit.eu – 0032 (0) 2 645 34 80
TRANSPARENCY REGISTER 268958411031-65
PRIVACY-POLICY | GENERAL TERMS OF SALES
The European Health Summit, hosted by the European Business Summits, is an annual gathering where businesses, policymakers, and academics come together to discuss important healthcare issues in Europe and beyond.
Speakers
Didier Reynders
European Commissioner for Justice
Martin Kocher
Minister for Labour and Economy, Austria
Emer Cooke
Executive Director of the European Medicines Agency
Laurent Muschel
Acting Director-General of HERA
Giorgos Rossides
Head of Cabinet of Commissioner Kyriakides
Pernille Weiss
Member of the European Parliament
Colin Scicluna
Head of Cabinet of Vice President Šuica
Dolors Montserrat
Member of the European Parliament
Lars Fruergaard Jørgensen
CEO, Novo Nordisk
Tomislav Sokol
Member of the European Parliament
Sara Cerdas
Member of the European Parliament
Carlos Montañés
Executive Vice-President, HIPRA
Haseeb Ahmad
President, Europe at Novartis
Jeffrey Francer
Vice President, Global Regulatory Affairs Policy, Eli Lilly
Massimo Giorgio Visentin
Eastern Europe Cluster President, Pfizer
Nathalie Moll
Director General, EFPIA
Dr. Gaudenz Silberschmidt
Director, Health and Multilateral Partnerships at the WHO
Adam Hacker
Director and Global Head Regulatory Affairs at CEPI
Francesca Colombo
Head of the Health Division, OECD
Irene Norstedt
Director People Directorate, DG Research and Innovation European Commission
Maya Matthews
Deputy Director for Digital, EU4Health and Health Systems Modernisation at DG SANTE
Prof. Karl Broich
President, Federal Institute for Drugs and Medical Devices
Josep Figueras
Director and Cofounder of the European Observatory on Health Systems and Policies
Dipak Kalra
President, The European Institute for Innovation through Health Data
Anca Toma
Executive Director of the European Patients’ Forum
Yann Le Cam
CEO, Eurordis
Charlotte Marchandise
Executive Director at the European Public Health Association (EUPHA)
Andrea Corazza
Senior Director, Policy & Government Affairs Europe, Novavax
Enrique Terol
Health Counsellor, Spanish Permanent Representation to the EU
Menno Kok
Managing Director, EIT Health
Elizabeth Kuiper
Associate Director, European Policy Centre
José Peres
Senior Coordinator of the National Associations Council at EuropaBio
Prof. Claire Paquet
Neurologist, Assistance Publique – Hôpitaux de Paris
Tamsin Rose
EU Health Reporter
Mariam Zaidi
International News Presenter
Sarah-Taïssir Bencharif
EU Health Journalist
Giedrė Peseckytė
EU Health Reporter, Euractiv
Andy Bounds
Financial Times Correspondent
Arnaud Thysen
Director General, European Business Summits
Felicia Balan
Health Project Manager, European Business Summits
EHS Weekly updates
EU Commissioner Didier Reynders will deliver a keynote speech at the 2023 edition of the European Health Summit on patients’ health data protection, taking into account the new European Health Data Space file.
The biotechnological pharmaceutical company HIPRA is joining EHS 2023, bringing its expertise as an established entity focused on prevention for animal and human health, with a broad range of highly innovative vaccines and an advanced diagnostic service:
“For a 100% European pharmaceutical company like HIPRA, being part of the European Business Summit is a thrilling opportunity to contribute to the policy debate that will help build a resilient European Health Union.“
Already a central topic at the European Health Summit (Summer Edition) and the focus of the October task force meeting, the Summit will address the EU Pharma Legislation, emphasising the need to strengthen the competitiveness and innovation of the healthcare system, with the ultimate aim of reaching autonomy.
The rapporteur of the directive of the EU Pharma Legislation, Member of the European Parliament Pernille Weiss will join EHS 2023 to discuss the next steps ahead for creating a competitive and innovative European healthcare system.
A longtime partner of EBS and participant to several task forces, Eli Lilly will be present at the 2023 edition of the European Health Summit to advance the discussion regarding an EU pharmaceutical strategy aimed at enhancing Europe’s global competitiveness.
EHS 2023 will explore the EU Commission’s €156 million initiative on NCDs in Europe, investigating how to ensure that such expenditure will have a positive impact for patients and what approaches are needed to reduce avoidable premature death while moving towards a preventative approach. Although the EU has unveiled a Beating Cancer Plan, how can the EU show more ambition towards diabetes and cardiovascular disease?
The rapporteur of the European Health Data Space, Member of the European Parliament Tomislav Sokol will join the 2023 edition of the European Health Summit, providing his insights on EU digital health, the secondary use of data and more.
The European Federation of Pharmaceutical Industries and Associations will participate to EHS 2023 to bring forward the debate on a pharma strategy to foster Europe’s competitiveness on a global scale.
A growing and aging global population strains healthcare systems. To enhance resilience, EHS 2023 will address factors like nutrition, sustainable food, environment, agriculture, fisheries, and climate policies in healthcare. The urgency of a One Health approach, spanning all sectors, is evident due to the COVID-19 pandemic and other disease outbreaks with their societal and economic consequences.
Make your voice heard
& join the debate!
Be heard
Choose the format that suits your strategy to reach key stakeholders: either thematic summits or tailor-made live bebates and interviews
Be seen
EBS has a database comprised of 17,000 contacts from the policy sector (40%), private sector (40%) and academia/Think Tanks (20%)
Learn from thought leaders
High-level EU representatives, C-level speakers and experts share their insights and bring complementary perspectives on key economical, political and social challenges.
Co-shape the debate
Co-shape your session together with EBS: from defining a session subject to selecting a panel composition and stakeholder outreach.
